CA-MA2

General Information


DRACP ID  DRACP00005

Peptide Name   CA-MA2

Sequence  KWKLFKKIPKFLHSAKKF

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Ceropin-Magainin hybrid peptides

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia IC50=35.1 µM MTT assay 3 days 1
A549 Lung adenocarcinoma Carcinoma IC50=25 µM MTT assay 3 days 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia IC50=20 µM MTT assay 3 days 1
MDA-MB-361 Breast adenocarcinoma Carcinoma IC50=28 µM MTT assay 3 days 1

Hemolytic Activity  Human erythrocytes: Hemolysis 0% (100 μM)

Normal (non-cancerous) Cytotoxicity  NIH-3T3 fibroblast: IC50>100 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  1D9M 

Predicted Structure  DRACP00005

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C115H180N28O20

Absent amino acids  CDEGMNQRTVY

Common amino acids  K

Mass  257827

Pl  11.58

Basic residues  8

Acidic residues  0

Hydrophobic residues  8

Net charge  8

Boman Index  -1907

Hydrophobicity  -63.89

Aliphatic Index  70.56

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  323.53

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 10675500

Title  Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells

Doi 10.1016/s0005-2736(99)00210-2

Year  2000

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.